EquitAI LogoEquitAI
$34.93
+1.51%
ROIV

ROIV

Roivant Sciences Ltd.

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
7/10
Quality
3/10
Growth
3/10
Strength
4/10
Dividend
1/10
Price Trend
Upwards
Momentum
Neutral
Balance Sheet
High Leverage
Earnings
Stable
Dividend Yield
0.00%
Market Cap
$25.23B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Roivant Sciences builds specialized subsidiary companies to rapidly develop innovative medicines and healthcare technologies. The company acquires overlooked drug candidates and provides the focused capital and talent needed to bring them to market. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...